About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Pancreatic Cancer Clinical Trials in Dallas | 209 Studies

Clinical Trials Pancreatic CancerDallas

Pancreatic Cancer Clinical Trials in Dallas

Find 209 clinical trials for pancreatic cancer near Dallas, Texas. Connect with research centers in your area.

All Pancreatic Cancer trials nationwide All trials in Dallas

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 61-80 of 209 trials

Active not recruitingTempus Priority Study: A Pan-tumor Observational StudyObservational study that will be collecting clinical and molecular health information from cancer patients who have received comprehensive genomic profiling and meet the specific…NCT05179824·Dallas, Texas and 1 other TerminatedA Study to Find a Suitable Dose of ASP4396 in Adults With Solid TumorsGenes contain genetic code which tell the body which proteins to make. Some types of cancer are caused by changes, or mutations, in a gene called KRAS.NCT06364696·Westwood, Kansas and 6 others

Pancreatic Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

Active not recruitingA Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic CancerSubjects will be offered the opportunity to participate in a randomized, controlled, 2-arm, unblinded multicenter trial (RCT).NCT03899636·Miami, Florida and 5 others

RecruitingA Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic AlterationsThis phase II study evaluates how well pemigatinib works for the treatment of adult patients with pancreatic cancer that has spread from where it first started to nearby tissue…NCT06906562·Birmingham, Alabama and 108 others

TerminatedStudy With Gemcitabine and RTA 402 for Patients With Unresectable Pancreatic CancerThis study assesses the safety and efficacy of RTA 402 in combination with gemcitabine in patients with unresectable pancreatic cancer.NCT00529113·Denver, Colorado and 4 others

CompletedEfficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005)The purpose of this study is to determine the safety and efficacy of combination therapy with pembrolizumab (MK-3475) and lenvatinib (E7080/MK-7902) in participants with triple…NCT03797326·Duarte, California and 87 others

CompletedXB2001 in Combination With ONIVYDE + 5-FU/LV (+Folinic Acid) in Advanced Pancreatic CancerThis trial will include 2 portions (phase 1 and phase 2).NCT04825288·Tucson, Arizona and 29 others

CompletedA Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced MalignanciesThis is a multicenter, open label, Phase 1 dose-escalation study of DSP-7888 Dosing Emulsion administered to adult patients with advanced malignancies.NCT02498665·Denver, Colorado and 7 others

TerminatedA Study of Creon (Pancrelipase) in Resected and Non-resected Pancreatic Cancer Participants With Exocrine Pancreatic Insufficiency (EPI)This is a study in participants with Exocrine Pancreatic Insufficiency (EPI) due to pancreatic cancer.NCT03859869·Birmingham, Alabama and 32 others

CompletedA Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)This is a Phase 1, multiple dose, ascending dose escalation study to define a MTD/RD and regimen of XmAb23104, to describe safety and tolerability, to assess PK and…NCT03752398·San Diego, California and 17 others

Active not recruitingStudy of Combined SGT-53 Plus Gemcitabine/Nab-Paclitaxel for Metastatic Pancreatic CancerThis clinical trial is an open label Phase II study of the combination of intravenously administered SGT-53 and gemcitabine/nab-paclitaxel in patients with metastatic pancreatic…NCT02340117·Dallas, Texas

RecruitingPTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)This is a multi-center, non-randomized, single-arm, open-label, phase Ib, dose escalation/dose expansion study of PTM-101 when combined with neoadjuvant chemotherapy for the…NCT06673017·Newport Beach, California and 7 others

CompletedStudy to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple MyelomaThe main purpose of this first human study with CC-223 is to assess the safety and action of a new class of experimental drug (dual mTOR inhibitors) in patients with advanced…NCT01177397·Los Angeles, California and 15 others

CompletedSafety Study of a Liposomal Docetaxel Formulation in Patients With Solid Tumors Who Have Failed Previous TherapiesThe purpose of this study is to determine the safety profile, including the maximum tolerated dose (MTD), of ATI-1123 a liposomal formulation of docetaxel, in the treatment of…NCT01041235·Dallas, Texas and 1 other

CompletedA Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine TreatmentThe purpose of this study is to look at the efficacy and safety of Irinotecan liposome injection in combination with other approved drugs used for cancer therapy, namely 5…NCT04083235·Birmingham, Alabama and 199 others

RecruitingA Study of LY4337713 in Participants With FAP-Positive Solid TumorsThis is a study of LY4337713 in participants with certain types of cancer that is advanced or has spread.NCT07213791·Newport Beach, California and 29 others

RecruitingBiospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 StudyThis clinical trial collects blood, saliva, urine, or stool samples to help identify possible genetic mutations that may increase a person's chance at developing pancreatic cancer.NCT06651580·Los Angeles, California and 25 others

TerminatedClinical Trial of Chemotherapy and Bemcentinib for Metastatic Pancreatic CancerDetermine the overall response rate (ORR) of bemcentinib plus chemotherapy (nab-paclitaxel/gemcitabine) in patients with metastatic pancreatic adenocarcinoma.NCT03649321·Dallas, Texas

CompletedPediatric Longitudinal Cohort Study of Chronic PancreatitisThe investigators will enroll a total of 628 patients under 18 years of age with ARP or CP.NCT03672422·Beverly Hills, California and 21 others

TerminatedStudy of Ruxolitinib in Pancreatic Cancer Patients (Janus 1)Determining the efficacy, based upon overall survival, of ruxolitinib added to capecitabine for the treatment of advanced or metastatic pancreatic cancer.NCT02117479·Avondale, Arizona and 229 others

PreviousPage 4 of 11Next

Other Conditions in Dallas

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia